EQS-News: OTCMKTS : $OCEL

Mittwoch, 16.11.22 19:20
Bildquelle: pixabay

EQS-News: Organicell Regenerative Medicine, Inc.
OTCMKTS : $OCEL 📋 Organicell Activates COPD Trial at Mayo Clinic!

16.11.2022 / 19:20 CET/CEST
The issuer is solely responsible for the content of this announcement.

Contact Details

Organicell Investor Relations

IR@organicell.com

Company Website

https://organicell.com/


News Source: News Direct

16.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Organicell Regenerative Medicine, Inc.
United States
ISIN: US68621D1072
EQS News ID: 1489793

 
End of News EQS News Service

1489793  16.11.2022 CET/CEST

Quelle: DGAP



Kontakt | Sitemap | Nutzungsbasierte Online Werbung | Werben auf boerse.de | Impressum | Disclaimer/Datenschutz